Transcriptomics

Dataset Information

Transcriptomic profiling of oxaliplatin- and SN-38-resistant Caco-2 colorectal adenocarcinoma cells in the proliferating and differentiated state


ABSTRACT: Acquired resistance to oxaliplatin and irinotecan/SN-38 limits the durability of colorectal cancer chemotherapy, but it is unclear whether prolonged exposure to different agents converges on a shared multidrug-resistant state or produces drug-specific adaptations, and how far the answer depends on the differentiation state in which it is measured. Oxaliplatin-resistant (Caco-2/ox) and SN-38-resistant (Caco-2/sn) Caco-2 sublines were generated by six months of stepwise dose escalation starting from the parental IC50, alongside a drug-naive control line (Caco-2/wt) carried through the identical culture and passaging regime without drug. All three lines were then maintained in drug-free medium for a further two months, so that the transcriptomes reported here describe a persistent adapted state rather than an acute drug response. Each line was profiled in the proliferating state (3 days after seeding) and in the differentiated, polarized state (3 weeks in culture), giving 24 libraries in total. The dataset was used to compare the breadth of the two resistant phenotypes, to examine drug transporter expression across the curated transportome, and to assess how differentiation state shapes the apparent transporter contribution to resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE354541 | GEO | 2026/11/16

REPOSITORIES: GEO